BIONIK LABORATORIES CORP. SECURED CONVERTIBLE PROMISSORY NOTESecured Convertible Promissory Note • February 8th, 2023 • Bionik Laboratories Corp. • Orthopedic, prosthetic & surgical appliances & supplies
Contract Type FiledFebruary 8th, 2023 Company IndustryThis Note is the convertible promissory note referred to in that certain Subscription Agreement dated as of the date hereof (the “Subscription Agreement”), between the Company and the Holder.
BIONIK LABORATORIES CORP. SECURED CONVERTIBLE PROMISSORY NOTESecured Convertible Promissory Note • November 17th, 2022 • Bionik Laboratories Corp. • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
Contract Type FiledNovember 17th, 2022 Company Industry JurisdictionThis Note is the convertible promissory note referred to in that certain Subscription Agreement dated as of the date hereof (the “Subscription Agreement”), between the Company and the Holder.
ContractSecured Convertible Promissory Note • November 4th, 2022 • Bionik Laboratories Corp. • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
Contract Type FiledNovember 4th, 2022 Company Industry JurisdictionTHIS NOTE HAS NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION, AND MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT IN COMPLIANCE WITH, OR PURSUANT TO AN EXEMPTION FROM, THE REQUIREMENTS OF SUCH ACT OR SUCH LAWS.
BIONIK LABORATORIES CORP. SECURED CONVERTIBLE PROMISSORY NOTESecured Convertible Promissory Note • June 14th, 2022 • Bionik Laboratories Corp. • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
Contract Type FiledJune 14th, 2022 Company Industry JurisdictionThis Note is a convertible promissory note referred to in that certain Subscription Agreement dated as of the date hereof, or series of like subscription agreements (individually or collectively, the “Subscription Agreement”), among the Company and the subscribers named therein, pursuant to which the Company is seeking to borrow up to $500,000 (the “Offering”).